DK1318820T3 - Drug containing xenon at subanesthetic concentrations for use as cardiovascular agent - Google Patents

Drug containing xenon at subanesthetic concentrations for use as cardiovascular agent

Info

Publication number
DK1318820T3
DK1318820T3 DK01972033T DK01972033T DK1318820T3 DK 1318820 T3 DK1318820 T3 DK 1318820T3 DK 01972033 T DK01972033 T DK 01972033T DK 01972033 T DK01972033 T DK 01972033T DK 1318820 T3 DK1318820 T3 DK 1318820T3
Authority
DK
Denmark
Prior art keywords
drug containing
cardiovascular agent
containing xenon
subanesthetic
concentrations
Prior art date
Application number
DK01972033T
Other languages
Danish (da)
Inventor
Carsten Pilger
Nicola Horn
Peter Neu
Klemens Thoma
Fridtjof Schucht
Jan-Hinrich Baumert
Klaus Hecker
Matthias Reyle-Hahn
Rolf Rossaint
Arnold Coppin
Original Assignee
Air Liquide Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Air Liquide Deutschland Gmbh filed Critical Air Liquide Deutschland Gmbh
Application granted granted Critical
Publication of DK1318820T3 publication Critical patent/DK1318820T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Gaseous medicament (A) comprises xenon (Xe). ACTIVITY : Cardiant; hypertensive; sedative; analgesic; vasotropic; MECHANISM OF ACTION : None given in the source material.
DK01972033T 2000-09-14 2001-09-10 Drug containing xenon at subanesthetic concentrations for use as cardiovascular agent DK1318820T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10045845A DE10045845A1 (en) 2000-09-14 2000-09-14 Xenon as a medicine
PCT/EP2001/010402 WO2002022141A2 (en) 2000-09-14 2001-09-10 Xenon as medicament

Publications (1)

Publication Number Publication Date
DK1318820T3 true DK1318820T3 (en) 2005-05-23

Family

ID=7656443

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01972033T DK1318820T3 (en) 2000-09-14 2001-09-10 Drug containing xenon at subanesthetic concentrations for use as cardiovascular agent

Country Status (8)

Country Link
EP (2) EP1318820B1 (en)
AT (1) ATE288275T1 (en)
AU (1) AU2001291844A1 (en)
DE (2) DE10045845A1 (en)
DK (1) DK1318820T3 (en)
ES (1) ES2236305T3 (en)
PT (1) PT1318820E (en)
WO (1) WO2002022141A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2321185T3 (en) * 2002-06-12 2009-06-03 Air Liquide Deutschland Gmbh BRAIN PROTECTION WITH A GAS CONTAINING XENON.
WO2003105872A1 (en) * 2002-06-12 2003-12-24 Messer Griesheim Gmbh Anti-spasmodic comprising xenon
DE10336768B4 (en) * 2002-08-10 2010-09-09 Air Liquide Deutschland Gmbh Drug for improving oxygenutilation
DE10336777B4 (en) * 2002-08-10 2012-05-31 Air Liquide Deutschland Gmbh Drug for cardiac stabilization
DE10336778B4 (en) * 2002-08-10 2010-09-16 Air Liquide Deutschland Gmbh Stabilizing a patient with a xenon-containing gas
AU2003288214A1 (en) * 2002-12-06 2004-06-30 Michael Georgieff Nasal pharmaceutical preparation containing an active lipophilic liquid or gaseous ingredient
FR2948878B1 (en) * 2009-08-04 2012-08-31 Air Liquide USE OF XENON TO TREAT PAIN HYPERSENSITIVITY
RU2506944C1 (en) * 2012-09-24 2014-02-20 Александр Юрьевич Верховский Method for improving transdermal permeability of therapeutic or cosmetic topical preparations, method for dermal administration of liquid xenon
JP6625966B2 (en) * 2013-03-15 2019-12-25 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム Noble gas-rich liquids and methods for their preparation and use
WO2018081821A1 (en) * 2016-10-31 2018-05-03 Nobilis Therapeutics, Inc. Treatment of anxiety disorder and augmentation of anti-anxiety interventions by administration of noble gas containing mixtures
WO2021195431A1 (en) * 2020-03-25 2021-09-30 The Brigham And Women's Hospital, Inc. Inhaled xenon therapy in neurodegenerative disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1601366A (en) * 1977-06-21 1981-10-28 Nat Res Dev Lasers
FR2538704B1 (en) * 1983-01-03 1986-02-28 France Prod Oxygenes Co CONTRAST PRODUCT OF TOMODENSITOMETRY IMAGES
US5099834A (en) * 1991-07-16 1992-03-31 Union Carbide Industrial Gases Technology Corporation Method for anesthesia
DE19709704C2 (en) * 1997-03-10 1999-11-04 Michael Georgieff Use of a liquid preparation of xenon for intravenous administration when inducing and / or maintaining anesthesia
DE19833014A1 (en) * 1998-07-23 2000-01-27 Messer Griesheim Gmbh Injectable anesthetic comprising noble gas(es) in gaseous form, also showing analgesic, sedative, antiinflammatory and muscle relaxant actions

Also Published As

Publication number Publication date
WO2002022141A3 (en) 2002-08-22
EP1570852A3 (en) 2005-11-23
EP1318820B1 (en) 2005-02-02
DE10045845A1 (en) 2002-04-04
WO2002022141A2 (en) 2002-03-21
ATE288275T1 (en) 2005-02-15
DE50105258D1 (en) 2005-03-10
ES2236305T3 (en) 2005-07-16
EP1318820A2 (en) 2003-06-18
PT1318820E (en) 2005-06-30
EP1570852A2 (en) 2005-09-07
AU2001291844A1 (en) 2002-03-26

Similar Documents

Publication Publication Date Title
DK1257254T3 (en) Formulations containing an anticholinergic drug for the treatment of chronic obstructive pulmonary disease
LTPA2011011I1 (en) Stable pharmaceutical solution formulations for pressurized metered dose inhalers
EP1330238A4 (en) Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
NO2013003I2 (en) Compounds as NS3 serine protease inhibitors for hepatitis C virus, pharmaceutical preparations and use of the compounds in the manufacture of a medicament
DK1318820T3 (en) Drug containing xenon at subanesthetic concentrations for use as cardiovascular agent
DE69942154D1 (en) MEDICATION-COMPATIBLE COMPOSITION IN AEROSOL FORM
ATE291898T1 (en) PHARMACEUTICAL AEROSOL FORMULATION CONTAINING SALMETEROL AND FLUTICASONE
DE60031504D1 (en) FLUTICASONPROPIONATE DRUG PREPARATION
ATE328587T1 (en) SOLID PHARMACEUTICAL COMPOSITION CONTAINING TILIDINE HYDROCHLORIDE